Cumulatively, it can be inferred that efficient monitoring of prothrombin time is a pre-requisite for performing efficient therapeutic procedures in an increasing set of the population, especially with cardiovascular disorders and the very recent (and critical) COVID associated coagulopathy state. Here, F2 is linked to blood coagulation disease.